Lemaitre Vascular LMAT
NASDAQ LMAT
$78.74 -0.73 (-0.92%)
As of: Sep 10, 2026 · 3:59 PM EDT

Lemaitre Vascular (LMAT) Change in Receivables (2010 - 2026)

Lemaitre Vascular's (LMAT) quarterly Change in Receivables came in at $396000.0 in Q2 2026, down 41.76% year-over-year from $680000.0 in Q2 2025, and down 84.04% quarter-over-quarter from $2.5 million in Q1 2026.

Analysis

Lemaitre Vascular (LMAT) Change in Receivables (2010 - 2026) Analysis & Trends

Lemaitre Vascular (LMAT) has reported Change in Receivables for 17 consecutive years, with $396000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Change in Receivables fell 41.76% year-over-year to $396000.0 in Q2 2026; TTM through Jun 2026 was $525000.0, a 89.95% decrease from a year earlier, with the FY2025 full-year figure at $2.9 million, down 54.08% from the prior year.
  • Change in Receivables was $396000.0 for Q2 2026 at Lemaitre Vascular, down from $2.5 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $5.8 million in Q1 2024 and troughed at -$3.9 million in Q3 2025.
  • A 5-year average of $1.1 million and a median of $969500.0 in 2023 frame the typical range for Change in Receivables.
  • Across the five-year window, Change in Receivables soared 357.0% in 2022 and slumped 513.59% in 2025, its largest moves.
  • Over 5 years, Change in Receivables stood at $1.8 million in 2022, then tumbled by 41.09% to $1.1 million in 2023, then slumped by 196.12% to -$1.0 million in 2024, then surged by 251.82% to $1.5 million in 2025, then sank by 74.35% to $396000.0 in 2026.
  • The last three Change in Receivables figures came in at $396000.0 (Q2 2026), $2.5 million (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 386.00 Mn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 74.90 Mn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn -224.00 Mn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 177.00 Mn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 46.00 Mn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 10.20 Mn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 172.10 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn -90.00 Mn
10 Lemaitre Vascular 1.80 Bn 1.43 Bn 50.76 Mn 396,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 396,000.00
Mar 31, 2026 2.48 Mn
Dec 31, 2025 1.54 Mn
Sep 30, 2025 -3.90 Mn
Jun 30, 2025 680,000.00
Mar 31, 2025 4.62 Mn
Dec 31, 2024 -1.02 Mn
Sep 30, 2024 942,000.00
Jun 30, 2024 743,000.00
Mar 31, 2024 5.75 Mn
Dec 31, 2023 1.06 Mn
Sep 30, 2023 -2.16 Mn
Jun 30, 2023 997,000.00
Mar 31, 2023 3.24 Mn
Dec 31, 2022 1.80 Mn
Sep 30, 2022 -873,000.00
Jun 30, 2022 659,000.00
Mar 31, 2022 1.95 Mn
Dec 31, 2021 393,000.00
Sep 30, 2021 -1.06 Mn